Atom Investors LP Biomarin Pharmaceutical Inc Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $352,615 - $391,619	4,145 New	4,145 $366,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $884,773 - $1.2 Million	-12,397 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$64.27 - $86.37 $2.78 Million - $3.74 Million	-43,306 Reduced 77.74%	12,397 $1.05 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $647,107 - $817,141	-9,601 Reduced 14.7%	55,703 $3.75 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $5.25 Million - $6.13 Million	65,304 New	65,304 $5.59 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.